Clinical Trials Logo

Myofascial Trigger Point Pain clinical trials

View clinical trials related to Myofascial Trigger Point Pain.

Filter by:

NCT ID: NCT06338514 Not yet recruiting - Clinical trials for Myofascial Trigger Point Pain

The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.

Start date: March 25, 2024
Phase: N/A
Study type: Interventional

Back pain is commonly seen in the working-age population, with the peak occurrence around the age of 40. Its frequency does not increase with age and is not associated with age-related degenerative changes in the spine. Especially when the underlying cause is conditions such as myofascial pain syndrome (MPS), where regional muscle sensitivity in the rhomboid and trapezius areas is prominent, dry needling treatment has become increasingly popular and the subject of numerous studies in recent years. In the diagnosis of MPS, two valuable findings include the detection of a taut band upon palpation and the presence of trigger points in muscle fibers with mild finger pressure. The study we are planning involves a double-blind efficacy trial where real and sham dry needling procedures will be performed under ultrasound guidance, ensuring that both the patient and the evaluator are blinded. This study design has the potential to make a significant contribution to the literature in this field.

NCT ID: NCT06273514 Completed - Clinical trials for Myofascial Trigger Point Pain

Comparison the Effects of TECAR With Dry Needling in the Treatment of Myofascial Trigger Points

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to assess the effectiveness of dry needling (DN) and capacitive and resistive transfer of energy (TECAR) therapy in the treatment of myofascial trigger points (MTrPs) as well comparison of their efficacy. Research hypothesis: Capacitive and resistive energy transfer therapy is comparable to dry needling therapy for the treatment of myofascial trigger points. It is estimated that the presence of trigger points is the main cause of pain in 30-85% of patients visiting primary health care facilities and pain management clinics. The presence of trigger points may significantly affect the patient's functional status and daily functioning. Recently, diagnostic criteria and methods of treating trigger points have evolved significantly. However, the usefulness of different imaging methods in the diagnosis of trigger points has not yet been established. Despite numerous studies, the long-term effectiveness of the dry needling method is still unknown. Furthermore, there is no available research on the short- and long-term effectiveness of capacitive and resistive energy transfer therapy in the treatment of trigger points. Therefore, the objectives of the work were: Determination and comparison of the short- and long-term effects of capacitive and resistive energy transfer therapy and the dry needling technique of myofascial trigger points located in the upper trapezius muscle (UT) on the strength, neck range of motion and pain intensity within this muscle. The study is planned to include a group of 26 men aged 25 to 45 who suffer from pain caused by the presence of myofascial trigger points in the upper trapezius muscle. The subjects will be divided into two groups of equal number of people. The first group will undergo therapy using the dry needling technique, while the second group will undergo capacitive and resistive energy transfer therapy. In order to determine the immediate effects of capacitive and resistive energy transfer therapy and dry needling techniques, measurements of muscle strength, the intensity of pain in the upper trapezius muscle and neck range of motion will be performed before and after each therapeutic session (2 session in 2 weeks are planed). In turn, to determine the long-term effects of capacitive and resistive energy transfer therapy and dry needling, the next above-mentioned measurements will be performed four weeks after the end of first therapy.

NCT ID: NCT06258070 Completed - Pain Clinical Trials

Clinical Performance of Therapeutic Use of BTX for Bruxism

BTX
Start date: September 1, 2009
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the performance of botulinum toxin (BTX) injections for bruxism. Participants were divided into two groups according to the duration of the symptoms. The main question is whether BTX should be reserved for long-standing bruxism where the conventional methods failed or indicated as a first-line treatment. The investigator also compared the required doses and the frequency of treatment sessions between these two groups for a complete recovery.

NCT ID: NCT06029413 Enrolling by invitation - Clinical trials for Trigger Point Pain, Myofascial

Myo vs. Myofascial Injection for Myofascial Trigger Points

Start date: September 26, 2023
Phase: N/A
Study type: Interventional

In this study, the effectiveness of two different application methods that can be used in myofascial trigger point injection treatment will be compared.

NCT ID: NCT06013644 Recruiting - Clinical trials for Myofascial Pain Syndrome

Acupuncture, Dry Needle and Botox Injection in Management of Patient With Myofascial Pain Dysfunction Syndrome

Start date: June 3, 2023
Phase: Early Phase 1
Study type: Interventional

Evaluating myofascial pain dysfunction symptoms using acupuncture, dry needle and Botox injection using electromyography and visual Analogue Scale on two time intervals at 2 and 6 months after the intervention

NCT ID: NCT05873010 Recruiting - Clinical trials for Myofascial Trigger Point Pain

Manual Compression and Stretching for The Myofascial Trigger Points in Upper Trapezius and Levator Scapulae

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

To compare the effectiveness of manual compression and stretching for myofascial trigger points in upper trapezius and levator scapulae in male office workers

NCT ID: NCT05851742 Recruiting - Clinical trials for Myofascial Trigger Point Pain

Effects of Myofascial Release and Electrical Stimulation in Chronic Pelvic Pain

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Myofascial pelvic pain (MFPP) caused by myofascial trigger points (MTrPs) is a major contributor to chronic pelvic pain in women.In females,pelvic pain is the single most common indication for referral to women's health services.Pelvic floor physical therapy with myofascial release improve mobility and reduce pain by releasing the painful trigger points.Tools that will be used,for pain numerical pain scale (NPS),functional pelvic pain scale(FPPS) and pelvic floor impact questionnaire-7 will be used to asses pain and functionality.

NCT ID: NCT05816161 Enrolling by invitation - Clinical trials for Myofascial Trigger Point Pain

Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

to findout the improvement by Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

NCT ID: NCT05792111 Recruiting - Clinical trials for Myofascial Trigger Point Pain

Caudal Epidural Steroid and Trigger Point Injection

Start date: October 12, 2022
Phase: Phase 4
Study type: Interventional

This prospective randomized study will be conducted in Bolu Abant İzzet Baysal University Hospital. Chronic low back and hip pain 72 patients aged between 18-70 years will be included in the study. The primary output of our study was NRS scores. The study of Manchikanti. L et al. (control group NRS reduction 4.4 ± 1.8; α margin of error 0.05, power 99%) (3) was taken as the basis for determining the sample size. Using the G Power 3 calculator program, 72 patients were identified to reduce their NRS scores by 25%. With a 20% exclusion rate, the total number of patients was calculated as 90

NCT ID: NCT05664165 Completed - Clinical trials for Myofascial Trigger Point Pain

The Efficiency of Dry Needling and Cold Spray-stretching Treatments

Start date: May 25, 2019
Phase: N/A
Study type: Interventional

A prospective randomized single-blind study included 60 patients aged 18-65 years who have MPS with active triger points in the upper trapezius muscle. Patients were randomized into two treatment groups as dry needling (DN) and cold spray-stretching. Both treatment groups received 1 treatment per week and totally 3 sessions. Evaluation parameters were pain level assessed by visual analog scale (VAS) and algometer, neck range of motion angles, functional level assessed by neck disability index (NDI). The effects of the treatments on active trigger points were evaluated by sEMG and US histogram. All parameters were evaluated at the beginning of the treatment and after 3 sessions of treatment. Algometer and sEMG were performed also before and after the 1st and 3rd sessions.